|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer 4/16/03 Norton Robert W 4 Officer 1:18K Pfizer Inc. |
Document/Exhibit Description Pages Size 1: 4 Form 4 - April 15, 2003 HTML 16K
|
FORM 4
[ ] Check this box if no longer
subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses) |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
OMB APPROVAL
OMB Number: 3235-0287
|
|
1. Name and Address of Reporting Person*
Norton, Robert W.
(Last) (First) (Middle)
Pfizer Inc. Att: Corporate Secretary
235 East 42nd Street
(Street)
(City) (State) (Zip)
|
2. Issuer Name and Ticker or Trading Symbol Pfizer Inc (PFE)
|
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable) Director
10% Owner
X Officer
Other
Senior Vice President
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
|
|
|
3. I.R.S. Identification
Number of Reporting Person, if an entity (voluntary) |
4. Statement for Month/Day/Year 5. If Amendment,
Date of Original (Month/Day/Year) |
||
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
|
1. Title of Security (Instr. 3) |
2. Transaction Date
(Month/Day/Year) |
2A. Deemed
Execution Date, if any (Month/Day/Year) |
3. Transaction Code and Voluntary Code (Instr. 8) Code | V
|
4. Securities Acquired (A) or Disposed (D) Of (Instr. 3, 4, and 5) Amount | A/D | Price
|
5. Amount of
Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) |
6. Owner-
ship Form: Direct(D) or Indirect (I) (Instr. 4) |
7. Nature of
Indirect Beneficial Ownership (Instr. 4) |
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
Persons who respond to the collection of information contained in this form are not required to
respond unless the form displays a currently valid OMB control number. |
(over)
SEC 1474 (9-02) |
| Norton, Robert W. - April 15, 2003 |
| Form 4 (continued) |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|
1. Title of Derivative Security
(Instr. 3) |
2. Conver-
sion or Exercise Price of Deri- vative Security |
3. Transaction
Date (Month/ Day/ Year) |
3A. Deemed
Execution Date, if any (Month/ Day/ Year) |
4. Transaction
Code and Voluntary (V) Code (Instr.8) Code | V
|
5. Number of Derivative Securities Acquired (A) or Disposed (D) Of (Instr. 3,4 and 5) |
6. Date Exercisable(DE) and
Expiration Date(ED) (Month/Day/Year) (DE) | (ED)
|
7. Title and Amount of
Underlying Securities (Instr. 3 and 4) |
8. Price
of Derivative Security (Instr.5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transactions (Instr.4) |
10. Owner- ship Form of Deriv- ative Security: Direct (D) or Indirect (I) (Instr.4) |
11. Nature of Indirect Beneficial Ownership (Instr.4) |
|
Phantom Stock Units (SSP) |
1-for-1 | 04/15/2003 |
|
A |
|
(A) 716 |
Immed. | (1)
|
Common Stock - 716 | $32.21 | 23,965 |
D
|
|
|
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. |
By: /s/ Margaret M. Foran
for Robert W. Norton 04-16-2003 ** Signature of Reporting Person Date Power of Attorney Page 2
|
| Norton, Robert W. - April 15, 2003 |
| Form 4 (continued) |
|
FOOTNOTE Descriptions for Pfizer Inc (PFE) Form 4 - April 15, 2003 Explanation of responses: (1) These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. |
| Page 3 |
| This ‘4’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 1/31/05 | 4 | |||
| Filed on: | 4/16/03 | 3, 4, 8-K, 8-K/A, S-8, S-8 POS | ||
| For Period end: | 4/15/03 | 4 | ||
| List all Filings | ||||